ATM phosphorylates ZBP-89 at Ser202 to potentiate p21waf1 induction by butyrate

Biochemical and Biophysical Research Communications

Volumn 359, Issue 3, 2007, Pages 817-821

  Bai, Longchuan ^a   Merchant, Juanita L ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Acetylation; Histone deacetylase inhibitor; Phosphorylation; Trichostatin A; ZNF148

Indexed keywords

ATM PROTEIN; BUTYRIC ACID; CYCLIN DEPENDENT KINASE INHIBITOR 1; DNA BINDING PROTEIN; PROTEIN P300; SERINE; ZINC FINGER PROTEIN;

ARTICLE; COLON MUCOSA; COMPLEX FORMATION; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION;

ANIMALS; BUTYRATES; CELL CYCLE PROTEINS; CELL LINE; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; HUMANS; HYDROXAMIC ACIDS; PHOSPHOSERINE; PROTEIN-SERINE-THREONINE KINASES; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

EID: 34250183104     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.05.197     Document Type: Article

References (27)

1. Bakkenist C.J., and Kastan M.B. DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature 421 (2003) 499-506
2. Boffa L.C., Vidali G., Mann R.S., and Allfrey V.G. Suppression of histone deacetylation in vivo and in vitro by sodium butyrate. J. Biol. Chem. 253 (1978) 3364-3366
3. Candido E.P., Reeves R., and Davie J.R. Sodium butyrate inhibits histone deacetylation in cultured cells. Cell 14 (1978) 105-113
4. Sealy L., and Chalkley R. The effect of sodium butyrate on histone modification. Cell 14 (1978) 115-121
5. Kruh J. Effects of sodium butyrate, a new pharmacological agent, on cells in culture. Mol. Cell. Biochem. 42 (1982) 65-82
6. Hassig C.A., Tong J.K., and Schreiber S.L. Fiber-derived butyrate and the prevention of colon cancer. Chem. Biol. 4 (1997) 783-789
7. Davie J.R. Inhibition of histone deacetylase activity by butyrate. J. Nutr. 133 (2003) 2485S-2493S
8. McIntyre A.G.P., and Young G.P. Butyrate production from dietary fibre and protection against large bowel cancer in a rat model. Gut 34 (1993) 386-391
9. Medina V.A.J., Alvarez-Arguelles H., Hernandez C., and Gonzalez F. Sodium butyrate inhibits carcinoma development in a 1,2-dimethylhydrazine-induced rat colon cancer. JPEN J. Parenter. Enteral Nutr. 22 (1998) 14-17
10. Kameue T.T., Yamada C.K., Koyama H., Iwasaki Y., Nakayama K., and Ushida K. Dietary sodium gluconate protects rats from large bowel cancer by stimulating butyrate production. J. Nutr. 134 (2004) 940-944
11. Van Lint C., Emiliani S., and Verdin E. The expression of a small fraction of cellular genes is changed in response to histone hyperacetylation. Gene Expr. 5 (1996) 245-253
12. Park C., Chamberlin M.E., Pan C.J., and Chou J.Y. Differential expression and butyrate response of human alkaline phosphatase genes are mediated by upstream DNA elements. Biochemistry 35 (1996) 9807-9814
13. Koyama N., Hoelzer D., and Ottmann O.G. Regulation of human IL-18 gene expression: interaction of PU.1 with GC-box binding protein is involved in human IL-18 expression in myeloid cells. Eur. J. Immunol. 34 (2004) 817-826
14. Boulaire J., Fotedar A., and Fotedar R. The functions of the cdk-cyclin kinase inhibitor p21WAF1. Pathol. Biol. (Paris) 48 (2000) 190-202
15. Ocker M., and Schneider-Stock R. Histone deacetylase inhibitors: signalling towards p21(cip1/waf1). Int. J. Biochem. Cell Biol. (2007)
16. Huang L., Sowa Y., Sakai T., and Pardee A.B. Activation of the p21WAF1/CIP1 promoter independent of p53 by the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) through the Sp1 sites. Oncogene 19 (2000) 5712-5719
17. Xiao H., Hasegawa T., and Isobe K. p300 collaborates with Sp1 and Sp3 in p21(waf1/cip1) promoter activation induced by histone deacetylase inhibitor. J. Biol. Chem. 275 (2000) 1371-1376
18. Bai L., and Merchant J.L. Transcription factor ZBP-89 cooperates with histone acetyltransferase p300 during butyrate activation of p21waf1 transcription in human cells. J. Biol. Chem. 275 (2000) 30725-30733
19. Merchant J.L., Bai L., and Okada M. ZBP-89 mediates butyrate regulation of gene expression. J. Nutr. 133 (2003) 2456S-2460S
20. Takeuchi A., Mishina Y., Miyaishi O., Kojima E., Hasegawa T., and Isobe K.I. Heterozygosity with respect to Zfp148 causes complete loss of fetal germ cells during mouse embryogenesis. Nat. Genet. 33 (2003) 172-176
21. Bai L., Kao J.Y., Law D.J., and Merchant J.L. Recruitment of ataxia-telangiectasia mutated to the p21(waf1) promoter by ZBP-89 plays a role in mucosal protection. Gastroenterology 131 (2006) 841-852
22. Ju R., and Muller M.T. Histone deacetylase inhibitors activate p21(WAF1) expression via ATM. Cancer Res. 63 (2003) 2891-2897
23. Taniuchi T., Mortensen E.R., Ferguson A., Greenson J., and Merchant J.L. Overexpression of ZBP-89, a zinc finger DNA binding protein, in gastric cancer. Biochem. Biophys. Res. Commun. 233 (1997) 154-160
24. Bai L., and Merchant J.L. ZBP-89 promotes growth arrest through stabilization of p53. Mol. Cell. Biol. 21 (2001) 4670-4683
25. Kuwabara M.D., and Sigman D.S. Footprinting DNA-protein complexes in situ following gel retardation assays using 1,10-phenanthroline-copper ion: Escherichia coli RNA polymerase-lac promoter complexes. Biochemistry 26 (1987) 7234-7238
26. Kastan L.D.M.B. The many substrates and functions of ATM. Nat. Rev. Mol. Cell Biol. 1 (2000) 179-186
27. Jones P.A., and Baylin S.B. The epigenomics of cancer. Cell 128 (2007) 683-692